ROPER TECHNOLOGIES INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ROPER TECHNOLOGIES INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	3,790	4,608	5,191	4,728	4,022	4,834	5,372	6,178	7,039	7,903
Cost of revenue	1,458	1,743	1,912	1,588	1,194	1,426	1,619	1,871	2,161	2,431
Gross profit	2,332	2,865	3,280	3,140	2,828	3,408	3,753	4,307	4,878	5,472
Research and development	195	281	377	380	382	485	530	646	748	853
Selling, general and administrative	1,278	1,655	1,883	1,812	1,745	2,072	2,228	2,562	2,882	3,237
Operating income	1,055	1,210	1,396	1,328	1,083	1,241	1,525	1,745	1,997	2,235
Interest expense	112	181	182	186	219	234	192	165	259	325
Other non-operating income	-1.5	5.1	0	-5.4	-3.1	24.6	-50.1	-2.8	-5	0.2
Pre-tax income	941	1,035	1,198	2,057	861	1,032	1,282	1,743	1,967	1,936
Income tax	282	62.9	254	417	188	227	296	375	418	400
Income from continuing operations				1,640	674	805	986	1,368	1,549	1,536
Net income	659	972	944	1,768	950	1,153	4,545	1,384	1,549	1,536
EBITDA	1,295	1,555	1,763	1,737	1,575	1,857	2,175	2,500	2,810	3,134
EPS, basic	6.50	9.51	9.15	17.02	9.08	10.95	42.92	12.98	14.47	14.30
EPS, diluted	6.43	9.39	9.05	16.82	8.98	10.82	42.55	12.89	14.35	14.20
Shares, basic (weighted)	101	102	103	104	105	105	106	107	107	107
Shares, diluted (weighted)	103	104	104	105	106	107	107	107	108	108
Dividend per share	1.25	1.46	1.70	1.90	2.10	2.31	2.54	2.80	3.08	3.39

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	757	671	364	710	308	352	793	214	188	297
Receivables	620	642	701	792	746	688	725	830	885	1,001
Inventory	182	205	191	199	165	69.2	111	119	121	142
Other current assets	55.9	73.5	80	97.6	114	136	151	165	196	236
Total current assets	1,777	1,759	1,611	2,000	1,752	2,421	1,932	1,481	1,543	1,928
Property, plant and equipment	141	143	129	140	127	82.7	85.3	120	150	157
Lease right-of-use assets				267	233	188	196	190	189	220
Goodwill	8,647	8,820	9,347	10,387	13,338	13,476	15,946	17,119	19,313	21,341
Intangible assets	3,656	3,475	3,842	4,668	7,168	6,509	8,031	8,212	9,060	9,764
Other non-current assets	73.5	88.3	101	391	386	370	395	408	443	517
Total assets	14,325	14,316	15,250	18,109	24,025	23,714	26,981	28,168	31,335	34,577
Accounts payable	152	171	165	162	178
Accrued liabilities	219	267	258	346	419	399	455	447	546	642
Deferred revenue	488	566	678	832	990	1,106	1,371	1,584	1,737	1,907
Short-term debt	401	801	1.5	602	499	799	699	500	1,043	705
Total current liabilities	1,445	2,029	1,448	2,397	2,444	3,122	2,893	2,963	3,832	3,726
Long-term debt	5,809	4,355	4,940	4,673	9,061	7,123	5,963	5,831	6,580	8,596
Lease liabilities				220	193	157	164	159	155	185
Other non-current liabilities	104	239	192	438	444	390	411	416	424	491
Total liabilities	8,536	7,453	7,511	8,617	13,545	12,150	10,943	10,723	12,467	14,696
Total debt	6,210	5,156	4,942	5,275	9,561	7,922	6,662	6,330	7,623	9,301
Paid-in capital	1,489	1,603	1,752	1,904	2,098	2,308	2,510	2,767	3,015	3,292
Retained earnings	4,642	5,465	6,248	7,818	8,546	9,456	13,731	14,816	16,035	17,206
Treasury stock	-18.9	-18.7	-18.5	-18.3	-18	-17.6	-17.2	-16.8	-16.5	-516
Other comprehensive income	-325	-186	-243	-213	-147	-183	-187	-123	-167	-101
Shareholders' equity	5,789	6,864	7,739	9,492	10,480	11,564	16,038	17,445	18,868	19,882
Total equity	5,789	6,864	7,739	9,492	10,480	11,564	16,038	17,445	18,868	19,882
Total liabilities and equity	14,325	14,316	15,250	18,109	24,025	23,714	26,981	28,168	31,335	34,577
Shares outstanding	102	103	103	104	105	106	106	107	107	107

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	659	972	944	1,768	950	1,153	4,545	1,384	1,549	1,536
Depreciation and amortization	241	345	367	409	492	616	650	755	813	898
Stock-based compensation	78.8	83.1	134	101	108	123	119	124	146	166
Change in inventory	6.3	-15.3	-21.8	-14.1	-8.4	-0.3	-43.1	-6.6	-1.9	-18.7
Change in payables	20.2	73.3	68.8	-7	4.9	16	21.3	18.2	-13	-3.9
Cash from operations	964	1,235	1,430	1,462	1,525	2,012	735	2,035	2,393	2,540
Capital expenditures	-37.3	-48.8	-49.1
Acquisitions	-3,722	-154	-1,276	-2,387	-6,018	-217	-4,280	-2,053	-3,613	-3,290
Cash from investing	-3,753	-210	-1,335	-1,296	-6,074	-143	1,210	-2,126	-3,469	-3,388
Debt issued	1,200	0	1,500	1,200	3,300	0	0	0	2,000	2,000
Debt repaid	0	-400	-1,300	0	-600	-500	-800	-700	-500	-1,000
Stock issued	28	61.3	58.8	64.9	106	105	110	147	126	115
Share buybacks								0	0	-500
Dividends paid	-121	-143	-170	-192	-214	-236	-262	-290	-322	-355
Cash from financing	2,805	-1,170	-388	177	4,137	-1,814	-1,465	-500	1,070	924
Exchange rate effect	-37.5	59.2	-13.8	2.5	10.5	-12.3	-37.5	12.2	-20.3	33.3
Net change in cash	-21.3	-85.9	-307	345	-401	43.2	441	-579	-26.1	109
Free cash flow	927	1,186	1,381
Interest paid	105	175	169	172	198	222	207	202	240	307
Income taxes paid	330	320	322	371	515			456	484	414

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $358.56 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	69.5%	Gross profit / revenue.
Operating margin	28.0%	Operating income / revenue.
EBITDA margin	28.5%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	35.9%	Pre-tax income / revenue.
Net margin	30.2%	Net income / revenue.
Operating cash flow margin	32.2%	Cash from operations / revenue.
Effective tax rate	15.8%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	13.4%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	7.1%	Net income / average total assets.
Return on invested capital (ROIC)	6.6%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	41.6%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	2.3%	Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue	0.5%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	12.3%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	13.7%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	14.5%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	12.2%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	13.4%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	14.1%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	11.9%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	13.6%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	15.6%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	11.5%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	13.0%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	14.8%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-0.8%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-30.3%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	10.1%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-1.0%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-30.6%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	9.6%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	6.1%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	51.2%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	10.7%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	10.1%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	10.1%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	10.1%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	5.4%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	7.4%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	13.7%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	10.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	8.6%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	7.6%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.2%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.4%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.5%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.55x	Current assets / current liabilities.
Quick ratio	0.37x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.11x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.61x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	32.2%	Total debt / total assets.
Liabilities / assets	46.8%	Total liabilities / total assets.
Net debt	$10.95B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	4.65x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	5.88x	Operating income / interest expense.
Working capital	-$1.55B	Current assets - current liabilities.
Goodwill and intangibles / assets	87.2%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$11.98B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.24x	Revenue / average total assets.
Fixed asset turnover	52.2x	Revenue / average property, plant and equipment.
Inventory turnover	17.4x	Cost of revenue / average inventory.
Days inventory	21 days	365 x average inventory / cost of revenue.
Receivables turnover	8.93x	Revenue / average receivables.
Days sales outstanding	41 days	365 x average receivables / revenue.

Per share

Metric	Value	How it is calculated
EPS, diluted	$24.89	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$82.31	Revenue / diluted weighted shares.
Operating cash flow per share	$26.53	Cash from operations / diluted weighted shares.
Book value per share	$189.08	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$121.11	Tangible book value / shares outstanding.
Cash per share	$3.69	(Cash + short-term investments) / shares outstanding.
Payout ratio	14.7%	Dividends paid / net income, when net income is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$35.46B	Share price x shares outstanding.
Enterprise value	$46.42B	Market cap + total debt - cash - short-term investments.
P/E	14.2x	Market cap / net income. Only when net income is positive.
P/S	4.28x	Market cap / revenue.
P/B	1.90x	Market cap / shareholders' equity. Only when equity is positive.
P/OCF	13.3x	Market cap / cash from operations, when positive.
EV/Sales	5.61x	Enterprise value / revenue.
EV/EBIT	20.0x	Enterprise value / operating income, when both are positive.
EV/EBITDA	19.7x	Enterprise value / EBITDA, when both are positive.
Earnings yield	7.1%	Net income / market cap (the inverse of P/E).
Dividend yield	1.0%	Dividends paid over the period / market cap.
Shareholder yield	1.0%	(Dividends paid + share buybacks) / market cap.

What was ROPER TECHNOLOGIES INC's revenue in fiscal 2025?

ROPER TECHNOLOGIES INC reported revenue of $7.90B for fiscal 2025, 12.3% higher than the year before.

Was ROPER TECHNOLOGIES INC profitable in fiscal 2025?

Yes. Net income was $1.54B, a net margin of 19.4%.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ROPER TECHNOLOGIES INC